近期代表性论文 (均为独立通讯作者)

1. Ying Y, Wang M, Chen Y, Li M, Ma C, Zhang J, Huang X, Jia M, Zeng J, Wang Y, Li L, Wang X, Tao Q, Shu XS*: Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci. Proc Natl Acad Sci USA 2022; 119 (22): e2120633119. （IF 11.1, 1区TOP）

2. Chen Y^#, Ying Y^#, Ma W^#, Ma H^#, Shi L, Gao X, Jia M, Li M, Song X, Kong W, Chen W, Zheng X, Muluh TA, Wang X, Wang M, Shu XS*. Targeting the epigenetic reader ENL inhibits super-enhancer-driven oncogenic transcription and synergizes with BET inhibition to suppress tumor progression. Cancer Research 2024; 84(8):1237-1251. （IF 12.5, 1区TOP）

3. Ying Y^#, Wang Y^#, Huang X, Sun Y, Zhang J, Li M, Zeng J, Wang M, Xiao W, Zhong L, Xu B, Li L, Tao Q, Wang X, Shu XS*: Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1, Oncogene 2020, 39(5):1004-1017.（IF 9.9, 1区TOP）

4. Zhang J^#, Ying Y^#, Li M^#, Wang M, Huang X, Jia M, Zeng J, Ma C, Zhang Y, Li C, Wang X, Shu XS*: Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer. Theranostics 2020; 10(22):10016-10030.（IF 11.6, 1区TOP）

5. Chen Y^#, Ying Y^#, Wang M^#, Ma C, Jia M, Shi L, Wang S, Zheng X, Chen W, Shu XS*: A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell Death & Disease 2023; 14(1): 8.（IF 8.1, 1区TOP）

Full list of publications

https://www.ncbi.nlm.nih.gov/myncbi/xingsheng.shu.1/bibliography/public/